Company: PFSA
Filing Date: 2025-02-18
Form Type: PRE 14A
Source: 0001213900-25-014919
Chunk: 18

Company: Profusa, Inc.
Filing Date: 2025-02-18
Form: PRE 14A
Chunk 18
---
) the public shareholder redemptions
would cause NorthView’s net tangible assets to be below $5,000,001.

You are not being asked to vote on a business combination at this time. If the Extension Amendment is implemented and you do not elect to redeem your public shares, provided that you are a stockholder on the record date for a meeting to consider the business combination, you will retain the right to vote on the business combination when it is submitted to stockholders, and you will have the right to redeem your public shares for cash in the event the business combination is approved and completed. You will also be entitled to receive your share of the funds in the Trust Account if we have not consummated a business combination by the Extended Date.

Required Vote

The affirmative vote of holders of at least 65% of the Company’s
outstanding shares of common stock, including the Founder Shares, is required to approve the Extension Proposal. If you do not vote, you
abstain from voting or you fail to instruct your broker or other nominee as to the voting of shares you beneficially own, your action
will have the same effect as a vote “AGAINST” the Extension Proposal.

<div align='center'>17</div>

If you do not want the Extension Proposal approved, you must
abstain, not vote, or vote “AGAINST” the Extension Amendment. You will be entitled to redeem your public shares for cash
in connection with the Extension Amendment whether or not you vote on the Extension Proposal, and regardless of how you vote, so
long as you exercise your redemption rights as described below under “Redemption Rights.” The Company anticipates that a
public stockholder who tenders shares for redemption in connection with the vote to approve the Extension Proposal would receive
payment of the redemption price for such shares soon after the implementation of the Extension.

Our Sponsor, all of our directors, executive officers and their affiliates,
and the Representatives are expected to vote any common stock owned by them in favor of the Extension Proposal. On the Record Date, our
Sponsor, directors and officers of the Company and their affiliates, and the Representatives beneficially owned and were entitled to vote
an aggregate of 5,193,750 shares, including 4,743,750 Founder Shares and 450,000 Representative Shares, representing approximately
88.3% of the Company’s issued and outstanding shares of common stock. Our Sponsor and our directors, executive officers and their
affiliates do not intend to